Safety and efficacy of an extended-release peptide YY analogue for obesity: A randomized, placebo-controlled, phase 1 trial. (2021)

First Author: Tan TM
Attributed to:  Next generation Y analogue for treatment of obesity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/dom.14358

PubMed Identifier: 33606914

Publication URI: http://europepmc.org/abstract/MED/33606914

Type: Journal Article/Review

Volume: 23

Parent Publication: Diabetes, obesity & metabolism

Issue: 7

ISSN: 1462-8902